sokol, this may not have been "Earth Shattering" news that catapults the SP as in announcing the start of the Retts Trial or the release of some amazingly good PK/PD data, but this should be placed in the same category, IMHO. This appears to validate ANAVEX even further. Dr Fadiran could have gone anywhere after serving as an officer for 24 years in the FDA. I would assume 90% of the time former FDA officers like him go to work for BIG $$$ at a BP they used to regulate. The fact that he chose to come to work for AVXL as Senior VP for Regulatory Affairs speaks volumes. He must know something very promising is cooking. The potential pay day and the decision he made to get in now on Misslings team while he can is very good news for everyone associated with the company... employees and shareholders alike. We are ready for liftoff.
News 
Market Data 
Discover 
